A recent study published in the December issue of the Journal of Gastroenterology and Hepatology highlights Vonoprazan's significant effectiveness in alleviating symptoms in patients with ...
The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...